){kind=logo}
){kind=logo}
Join ACMG Foundation’s Corporate Partners on Wednesday, March 11, from 12:15 PM – 1:15 PM for one-hour lunchtime sessions spotlighting the latest trends, innovations, and developments in genomic medicine. These sessions foster collaboration between industry and genetics professionals, offering insights into cutting-edge technologies and best practices. Open to all attendees, pre-registration is required as space is limited.
This is a promotional activity and does not carry educational credit. These are Company-Directed Programs and are not endorsed or sponsored by ACMG.
BioMarin Pharmaceutical Inc.
Wednesday, March 11, 2026
12:15 PM - 1:15 PM
Baltimore Convention Center
Room 337-338
Unlocking Possibilities in PKU – A Review of New Clinical Trial Data
Speakers: Melissa Lah, MD, Indiana University School of Medicine
Caregiver of an individual with PKU
MyOme Inc.
Wednesday, March 11, 2026
12:15 PM - 1:15 PM
Baltimore Convention Center
Room 341-342
A New Lens in Rare Disease Diagnosis
Speaker(s): Akash Kumar, MD, PhD,, MyOme
Danny Miller, MD, PhD, University of Washington
Monica Hsiung Wojcik, MD, MPH, Boston Children's Hospital
For more information and to register
Natera
Wednesday, March 11, 2026
12:15 PM - 1:15 PM
Baltimore Convention Center
Room 343-344
Advancing Genetic Insight from Prenatal Screening Through Rare Disease Diagnosis
Speaker(s): Rupin Dhamankar, MS, CGC, Natera
Val Kantor, Natera
Brian Schoenfeld, MS, LCGC, Natera
For more information and to register
PTC Therapeutics US, Inc.
Wednesday, March 11, 2026
12:15 PM - 1:15 PM
Baltimore Convention Center
Room 324-326
Session Title: Redefining Standards in PKU Care: New Data and Real-World Case Studies
Speakers: Can Ficicioglu, MD, PhD, The Children's Hospital of Philadelphia
For more information and to register